DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension

Information source: China-Japan Friendship Hospital
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Diabetes Mellitus; Essential Hypertension

Intervention: Fosinopril (Drug); Metformin (Drug)

Phase: N/A

Status: Completed

Sponsored by: China-Japan Friendship Hospital

Summary

The objective of this study is to investigate the effect of metformin on the correlation between hyperinsulinemia and hypertension.

Clinical Details

Official title: The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: Blood pressure measurement

Eligibility

Minimum age: 20 Years. Maximum age: 65 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- 20 to 65 years of age, regardless of sex

- duration of hypertension was <5 years

- overweight or obesity, mild to moderate hypertension, receive no euglycemic agent or

antiobesity drug

Locations and Contacts

Additional Information

Starting date: May 2006
Last updated: May 11, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017